基于创新扩散理论的循证护理对慢性乙型肝炎患者生存质量和自我效能感的影响

Effect of evidence-based nursing based on Diffusion of Innovations Theory on life quality and self-efficacy of patients with chronic hepatitis B

目的探究实施基于创新扩散理论的循证护理对慢性乙型肝炎患者生存质量和自我效能感的影响。方法以张家港市第一人民医院2016年3月至2017年2月收治的62例慢性乙型肝炎患者为对照组,住院期间予以常规护理干预;2017年3月至2018年2月收治的62例慢性乙型肝炎患者为研究组,予以基于创新扩散理论的循证护理措施。回顾性比较在护理干预前及干预后4周两组患者的SF-36生活质量量表、自我效能量表的评分情况。结果研究组在干预4周后的SF-36生活质量量表中身体状况、心理状况、社会功能、角色功能、总体生活质量评分均高于对照组(P<0.05),在运动规模、疾病信息、获得帮助、与医师沟通、一般疾病管理、做家务、社会娱乐活动、症状管理、饮食管理、情绪控制的自我效能评分均高于对照组(P<0.05)。结论基于创新扩散理论的循证护理应用于慢性乙型肝炎患者,能改善其生存质量,且能提高其自我效能感。

Objective To explore the effect of evidence-based nursing based on Diffusion of Innovations Theory on the quality of life and self-efficacy of patients with chronic hepatitis B. Methods Sixty-two patients with chronic hepatitis B admitted to the First People's Hospital of Zhangjiagang City from March 2016 to February 2017 were enrolled into control group with routine nursing intervention being applied.Sixty-two patients with chronic hepatitis B admitted from March 2017 to February 2018 were selected as the study group who received the evidence-based nursing based on Diffusion of Innovations Theory.The SF-36 life quality scale and self-efficacy scale were used to evaluate the effects of the intervention before and 4 weeks retrospectively. Results The scores of physical condition,psychological status,social function,role function and overall quality of life in study group after 4 weeks of intervention were higher than those of the control group ( P <0.05 ).The scores of exercise scale,disease information,assistance,communication with doctors,general disease management,housework,social recreational activities,etc.were higher in the study group than those in the control group ( P <0.05 ).The self-efficacy scores of symptom management,diet management and emotional control were higher than those of the control group ( P <0.05 ). Conclusions Evidence-based nursing based on Diffusion of Innovations Theory can improve the quality of life and self-efficacy of patients with chronic hepatitis B.